European Medicines Agency recommends new contraindication for Fareston (toremifene)

View source ↗

Summary

The EMA recommended a new contraindication for Fareston (toremifene), highlighting situations where the drug should not be used due to safety concerns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FARESTON (toremifene citrate)